Literature DB >> 28250459

Rheumatoid Arthritis: Baricitinib more effective than adalimumab.

Jessica McHugh.   

Abstract

Entities:  

Year:  2017        PMID: 28250459     DOI: 10.1038/nrrheum.2017.32

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  1 in total

1.  Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.

Authors:  Peter C Taylor; Edward C Keystone; Désirée van der Heijde; Michael E Weinblatt; Liliana Del Carmen Morales; Jaime Reyes Gonzaga; Sergey Yakushin; Taeko Ishii; Kahaku Emoto; Scott Beattie; Vipin Arora; Carol Gaich; Terence Rooney; Douglas Schlichting; William L Macias; Stephanie de Bono; Yoshiya Tanaka
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.